Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Colon Targeting Drug Delivery Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Colon Targeting Drug Delivery Market Trends and Forecast

The future of the global colon targeting drug delivery market looks promising with opportunities in the hospital, clinic, and biology laboratory markets. The global colon targeting drug delivery market is expected to grow with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are increased demand for effective treatment options, innovations in pharmaceutical technologies, including biodegradable polymers, pH-sensitive coatings, and nanoparticles, and rising elderly population.
• Lucintel forecasts that pressure controlled drug-delivery system is expected to witness the highest growth over the forecast period.
• Within this market, hospital is expected to witness the highest growth.
• APAC is expected to witness the highest growth over the forecast period.

Colon Targeting Drug Delivery Market Trends and Forecast

Country Wise Outlook for the Colon Targeting Drug Delivery Market

• United States - Pfizer announced advancements in colon-specific drug delivery technologies for treating inflammatory bowel disease, aiming to enhance patient outcomes. Government grants support research into novel drug formulations targeting colon-specific diseases.

• India - Sun Pharmaceutical Industries launched a new colon-targeted drug for ulcerative colitis, expanding its portfolio in gastrointestinal therapeutics. Government initiatives encourage domestic pharmaceuticals to innovate and address local health challenges.

• Germany - Bayer AG developed a novel colon-targeting drug delivery system for improving efficacy in colorectal cancer treatments. Collaborative research projects with universities receive government funding to advance precision medicine.

• Japan - Takeda Pharmaceutical Company expanded its pipeline with a colon-targeted formulation for CrohnÄX%$%Xs disease, leveraging biotechnology partnerships. Government subsidies support clinical trials and regulatory approvals for innovative drug delivery systems.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Colon Targeting Drug Delivery Market by Segment

Colon Targeting Drug Delivery Market by Segment

The study includes a forecast for the global colon targeting drug delivery market by type, application, and region.

Colon Targeting Drug Delivery Market by Type [Value from 2018 to 2030]:


• Pressure Controlled Drug-Delivery Systems
• Novel Colon Targeted Delivery System (CODESTM)
• Osmotic Controlled Drug Delivery (ORDS-CT)
• Others

Colon Targeting Drug Delivery Market by Application [Value from 2018 to 2030]:


• Hospital
• Clinic
• Biology Laboratory
• Others

Colon Targeting Drug Delivery Market by Region [Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Colon Targeting Drug Delivery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colon targeting drug delivery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colon targeting drug delivery companies profiled in this report include-
• Baxter International
• 3M Health Care
• Bayer
• Boston Scientific Corporation
• F. Hoffmann-La Roche
• Glaxosmithkline
• Johnson and Johnson
• Novartis
• Sanofi
• Bausch Health

Recent Development in the Colon Targeting Drug Delivery Market

• GlaxoSmithKline : GlaxoSmithKline introduced a new colon-targeting drug delivery system for treating ulcerative colitis, enhancing localized treatment efficacy.

• AstraZeneca : AstraZeneca developed a novel oral formulation with colon-specific release mechanisms for improving drug bioavailability in gastrointestinal therapies.

• Novartis : Novartis launched a specialized colon-targeted drug delivery platform for personalized treatment of colorectal cancer, focusing on enhanced therapeutic outcomes.

• Merck & Co., Inc. : Merck & Co., Inc. expanded its portfolio with a colon-targeted drug delivery technology aimed at improving patient compliance and treatment effectiveness in inflammatory bowel diseases.



Features of the Global Colon Targeting Drug Delivery Market

Market Size Estimates: Colon targeting drug delivery market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Colon targeting drug delivery market size by type, application, and region in terms of value ($B).
Regional Analysis: Colon targeting drug delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the colon targeting drug delivery market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colon targeting drug delivery market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for colon targeting drug delivery market?
Answer: The global colon targeting drug delivery market is expected to grow with a CAGR of 7.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the colon targeting drug delivery market?
Answer: The major drivers for this market are increased demand for effective treatment options, innovations in pharmaceutical technologies, including biodegradable polymers, pH-sensitive coatings, and nanoparticles, and rising elderly population.
Q3. What are the major segments for colon targeting drug delivery market?
Answer: The future of the global colon targeting drug delivery market looks promising with opportunities in the hospital, clinic, and biology laboratory markets.
Q4. Who are the key colon targeting drug delivery market companies?
Answer: Some of the key colon targeting drug delivery companies are as follows:
• Baxter International
• 3M Health Care
• Bayer
• Boston Scientific Corporation
• F. Hoffmann-La Roche
• Glaxosmithkline
• Johnson and Johnson
• Novartis
• Sanofi
• Bausch Health
Q5. Which colon targeting drug delivery market segment will be the largest in future?
Answer: Lucintel forecasts that pressure controlled drug-delivery system is expected to witness the highest growth over the forecast period.
Q6. In colon targeting drug delivery market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the colon targeting drug delivery market by type (pressure controlled drug-delivery systems, novel colon targeted delivery system (CODESTM), osmotic controlled drug delivery (ORDS-CT), and others), application (hospital, clinic, biology laboratory, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Colon Targeting Drug Delivery Market Market, Colon Targeting Drug Delivery Market Market Size, Colon Targeting Drug Delivery Market Market Growth, Colon Targeting Drug Delivery Market Market Analysis, Colon Targeting Drug Delivery Market Market Report, Colon Targeting Drug Delivery Market Market Share, Colon Targeting Drug Delivery Market Market Trends, Colon Targeting Drug Delivery Market Market Forecast, Colon Targeting Drug Delivery Market Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Colon Targeting Drug Delivery Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Colon Targeting Drug Delivery Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Colon Targeting Drug Delivery Market by Type
3.3.1: Pressure Controlled Drug-Delivery Systems
3.3.2: Novel Colon Targeted Delivery System (CODESTM)
3.3.3: Osmotic Controlled Drug Delivery (ORDS-CT)
3.3.4: Others
3.4: Global Colon Targeting Drug Delivery Market by Application
3.4.1: Hospital
3.4.2: Clinic
3.4.3: Biology Laboratory
3.4.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Colon Targeting Drug Delivery Market by Region
4.2: North American Colon Targeting Drug Delivery Market
4.2.1: North American Colon Targeting Drug Delivery Market by Type: Pressure Controlled Drug-Delivery Systems, Novel Colon Targeted Delivery System (CODESTM), Osmotic Controlled Drug Delivery (ORDS-CT), and Others
4.2.2: North American Colon Targeting Drug Delivery Market by Application: Hospital, Clinic, Biology Laboratory, and Others
4.3: European Colon Targeting Drug Delivery Market
4.3.1: European Colon Targeting Drug Delivery Market by Type: Pressure Controlled Drug-Delivery Systems, Novel Colon Targeted Delivery System (CODESTM), Osmotic Controlled Drug Delivery (ORDS-CT), and Others
4.3.2: European Colon Targeting Drug Delivery Market by Application: Hospital, Clinic, Biology Laboratory, and Others
4.4: APAC Colon Targeting Drug Delivery Market
4.4.1: APAC Colon Targeting Drug Delivery Market by Type: Pressure Controlled Drug-Delivery Systems, Novel Colon Targeted Delivery System (CODESTM), Osmotic Controlled Drug Delivery (ORDS-CT), and Others
4.4.2: APAC Colon Targeting Drug Delivery Market by Application: Hospital, Clinic, Biology Laboratory, and Others
4.5: ROW Colon Targeting Drug Delivery Market
4.5.1: ROW Colon Targeting Drug Delivery Market by Type: Pressure Controlled Drug-Delivery Systems, Novel Colon Targeted Delivery System (CODESTM), Osmotic Controlled Drug Delivery (ORDS-CT), and Others
4.5.2: ROW Colon Targeting Drug Delivery Market by Application: Hospital, Clinic, Biology Laboratory, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Colon Targeting Drug Delivery Market by Type
6.1.2: Growth Opportunities for the Global Colon Targeting Drug Delivery Market by Application
6.1.3: Growth Opportunities for the Global Colon Targeting Drug Delivery Market by Region
6.2: Emerging Trends in the Global Colon Targeting Drug Delivery Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Colon Targeting Drug Delivery Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colon Targeting Drug Delivery Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Baxter International
7.2: 3M Health Care
7.3: Bayer
7.4: Boston Scientific Corporation
7.5: F. Hoffmann-La Roche
7.6: Glaxosmithkline
7.7: Johnson and Johnson
7.8: Novartis
7.9: Sanofi
7.10: Bausch Health
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Colon Targeting Drug Delivery Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
A 150 Page Report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.